Search research articles
Contact Us
Filters
Showing results (151-160 of 257) with videos related to
Page
of 26
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 10, 2017
Five-Year Summary of <i>In Vitro</i> Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)
Michael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2025
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023)
Helio S Sader, Marisa L Winkler, Krisztina M Papp-Wallace, et al.
Journal of Clinical Microbiology
|
November 6, 2015
Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants
Rodrigo E Mendes, Amy A Watters, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2012
Linezolid surveillance results for the United States: LEADER surveillance program 2011
Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
December 6, 2016
Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate
Michael A Pfaller, Rodrigo E Mendes, Robert K Flamm, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013)
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2014
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy
|
July 9, 2018
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16
Michael A Pfaller, Rodrigo E Mendes, Leonard R Duncan, et al.
Diagnostic Microbiology and Infectious Disease
|
March 3, 2009
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents
Rodrigo E Mendes, Paul R Rhomberg, Jan M Bell, et al.
Antimicrobial Agents and Chemotherapy
|
February 10, 2016
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014
Helio S Sader, Robert K Flamm, Rodrigo E Mendes, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 257) with videos related to
Sort By:
Page
of 26
Antimicrobial Agents and Chemotherapy
|
May 10, 2017
Five-Year Summary of <i>In Vitro</i> Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)
Michael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2025
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023)
Helio S Sader, Marisa L Winkler, Krisztina M Papp-Wallace, et al.
Journal of Clinical Microbiology
|
November 6, 2015
Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants
Rodrigo E Mendes, Amy A Watters, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2012
Linezolid surveillance results for the United States: LEADER surveillance program 2011
Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
December 6, 2016
Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate
Michael A Pfaller, Rodrigo E Mendes, Robert K Flamm, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013)
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2014
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy
|
July 9, 2018
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16
Michael A Pfaller, Rodrigo E Mendes, Leonard R Duncan, et al.
Diagnostic Microbiology and Infectious Disease
|
March 3, 2009
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents
Rodrigo E Mendes, Paul R Rhomberg, Jan M Bell, et al.
Antimicrobial Agents and Chemotherapy
|
February 10, 2016
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014
Helio S Sader, Robert K Flamm, Rodrigo E Mendes, et al.
Page
of 26